Equity-Based Compensation - Schedule of Equity-based Compensation Expense on Statement of Operations (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total equity-based compensation expense	[1]	$ 18,687	$ 30,511	$ 58,833	$ 93,185
Stock Appreciation Rights (SARs)
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total equity-based compensation expense					11,399
Selling, General and Administrative Expenses
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total equity-based compensation expense		16,775	28,076	52,082	81,727
Medical Expenses
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total equity-based compensation expense		$ 1,912	$ 2,435	$ 6,751	$ 11,458

[1] Total equity-based compensation expense for the nine months ended September 30, 2021, includes $11,399 for cash settlement of SARs related to the IPO.